Plasmablastic transformation of low-grade CD5+ B-cell lymphoproliferative disorder with MYC gene rearrangements
Zenggang Pan(University of Colorado Anschutz Medical Campus), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Qingmei Xie(South China Agricultural University), Wing C. Chan(Ontario Institute for Cancer Research), Bill G. Richendollar(DeKalb Medical Center), Susan Repertinger(CHI Health Creighton University Medical Center - Bergan Mercy)
Cited by 18
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Oncogenically active MYD88 mutations in human lymphoma
|Nature|2010|1.5k